Biogen Pharmachem Industries Ltd — Updates, 23-07-2025: Company Update

Biogen Pharmachem Industries has confirmed no deviation in the utilization of funds raised from its Preferential Issue. The company secured Rs 25 Crore on April 15, 2025, explicitly for business expansion and general corporate purposes. As of June 30, 2025, the entire Rs 25 Crore has been utilized precisely as intended for these stated objectives. This update assures investors that the funds from the preferential issue have been deployed consistent with the company's announced plans and business growth strategy.